Clinical, radiologic, and pathologic features and outcomes of pulmonary transthyretin amyloidosis
- 8 February 2022
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 194, 106761
Abstract
No abstract availableKeywords
Funding Information
- Mayo Clinic
This publication has 28 references indexed in Scilit:
- Safety and Efficacy of RNAi Therapy for Transthyretin AmyloidosisNew England Journal of Medicine, 2013
- Nodular Pulmonary Amyloidosis Is Characterized by Localized Immunoglobulin Deposition and Is Frequently Associated With an Indolent B-cell Lymphoproliferative DisorderAmerican Journal of Surgical Pathology, 2013
- Guideline of transthyretin-related hereditary amyloidosis for cliniciansOrphanet Journal of Rare Diseases, 2013
- Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem studyLaboratory Investigation, 2011
- Aging and transthyretin-related amyloidosis: Pathologic examinations in pulmonary amyloidosisAmyloid, 2006
- Interpretative strategies for lung function testsEuropean Respiratory Journal, 2005
- Pulmonary marginal zone lymphoma of MALT type as a cause of localised pulmonary amyloidosisJournal of Clinical Pathology, 2001
- Pulmonary Amyloidosis. The Mayo Clinic Experience from 1980 to 1993Annals of Internal Medicine, 1996
- Type and distribution of pulmonary parenchymal and vascular amyloidThe American Journal of Medicine, 1979
- Pleural Effusions: The Diagnostic Separation of Transudates and ExudatesAnnals of Internal Medicine, 1972